News

The Lancet22h
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study ...
We did a single-centre, dose-escalation and dose-expansion, phase 1/2, clinical trial. Patients with treatment-naive higher-risk-myelodysplastic syndromes or chronic myelomonocytic leukaemia (risk ...
Amber alert over 'killer' temperatures: Government scientists sound alarm as Britain is set to hit 34C on hottest weekend of the year
The Government's UK Health Security Agency (UKHSA) warned that the heatwave could bring 'a rise in deaths, particularly among ...